InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
T+90 hit rate
42%
T+90 mean return
-3.7%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Lippoldt Darin, Directeur Juridique. Officer active across 1 company, notably Neurocrine Biosciences INC. Aggregated, 34 filings have been logged. Split: 0 buy · 13 sells. Total volume traded: €2.1m. History available since 10 December 2021. The latest transaction was filed on 8 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations34 total
200 sharesCommon StockSEC:0001504783-26-000015:0
200 sharesCommon StockSEC:0001504783-26-000015:1
8,110 sharesCommon StockSEC:0001504783-26-000015:2
8,110 sharesCommon StockSEC:0001504783-26-000015:3
1,690 sharesCommon StockSEC:0001504783-26-000015:4
1,690 sharesCommon StockSEC:0001504783-26-000015:5
4,376 shares@ US$43.2437.3% of flowCommon StockSEC:0001504783-25-000006
4,376 shares@ US$43.240.0011% mcap37.3% of flowCommon StockSEC:0001504783-25-000006:0
190 shares0Common StockSEC:0000914475-25-000065:0
1,727 shares0Common StockSEC:0000914475-25-000050:0
2,373 shares0Common StockSEC:0000914475-25-000026:0
2,996 shares@ US$79.023.5% of flowCommon StockSEC:0000914475-24-000185:0
7,004 shares@ US$79.028.2% of flowCommon StockSEC:0000914475-24-000168:0
1,098 shares@ US$132.99492.2% of flowCommon StockSEC:0000914475-24-000074:0
1,041 shares@ US$142.16632.2% of flowCommon StockSEC:0000914475-24-000048:0
1,250 shares@ US$140.64782.6% of flowCommon StockSEC:0000914475-24-000029:0
10,000 shares@ US$79.0211.7% of flowCommon StockSEC:0000914475-24-000011:0
20,830 shares@ US$43.2413.4% of flowCommon StockSEC:0000914475-23-000082:0
10,919 shares@ US$112.273218.0% of flowCommon StockSEC:0001209191-23-056907:0
190 shares0Common StockSEC:0001209191-23-047966:0
2,132 shares@ US$107.3883.4% of flowCommon StockSEC:0001209191-23-047138:0
1,041 shares@ US$105.80351.6% of flowCommon StockSEC:0001209191-23-007913:0
1,250 shares@ US$109.97122.0% of flowCommon StockSEC:0001209191-23-006277:0
5,082 shares@ US$43.243.5% of flowCommon StockSEC:0001209191-22-056436:0
4,518 shares@ US$43.243.2% of flowCommon StockSEC:0001209191-22-055837:0
25 of 34 declarations
About Lippoldt Darin
Darin Lippoldt is the Chief Legal Officer of Neurocrine Biosciences Inc. He is responsible for managing the company's legal affairs, including regulatory compliance and intellectual property issues. His role is crucial in protecting Neurocrine's legal interests and supporting its business objectives.
